button bars forest bayes pooled summary circles
 
deaths (OS)progression or deaths (PFS)RFS/DFS

metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)

versus pegylated liposomal doxorubicin
avelumab alone vs. pegylated liposomal doxorubicin 1 certainty unassessable+14% certainty unassessable+68%-
avelumab plus pegylated liposomal doxorubicin vs. pegylated liposomal doxorubicin 1 certainty unassessable-10% certainty unassessable-20%-

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons